Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2009; 15(47): 5983-5991
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5983
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5983
Table 3 Survival rate estimates of patients with ESCC for neoadjuvant chemoradiotherapy compared with surgery alone
| Overall survival | No. of studies | No. of patients | OR (95% CI) | P | |
| CRT + S | S | ||||
| 1 yr | 6 | 368 | 368 | 1.16 (0.85, 1.57) | 0.34 |
| 3 yr | 7 | 390 | 391 | 1.34 (0.98, 1.82) | 0.07 |
| 5 yr | 5 | 293 | 295 | 1.41 (0.98, 2.02) | 0.06 |
- Citation: Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(47): 5983-5991
- URL: https://www.wjgnet.com/1007-9327/full/v15/i47/5983.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5983